Multi-band synergistic phototherapy bacteriostatic nursing device

Abstract

The invention discloses an antibacterial nursing device for multiband synergistic phototherapy. The antibacterial nursing device comprises a device body and an LED light source arranged in the device body. The LED light source comprises but is not limited to blue light, red light, green light, near blue light and yellow light, and each light source group can be continuously used in a single wavelength manner or alternately used in a multi-wavelength combination manner; by arranging various lights with specific wavelengths and matching with a flexible light combination mode, different nursing effect requirements of private parts such as vagina and breasts are accurately met. Each light can support independent use of a single wavelength or combined alternate use of multiple wavelengths, and through diversified light selection and combination design, the requirements of different scenes such as vagina daily nursing, bacteriostatic protection, sensitive soothing, breast blood circulation promotion, damage repair, skin brightening and maintenance and the like can be met in a targeted mode. The multi-dimensional demands of private part nursing are fully covered, and the problems that in the prior art, a single-wavelength light source is single in nursing effect and cannot adapt to complex nursing requirements are effectively solved.

Description

Technical Field

[0001] This invention belongs to the field of antibacterial device technology and relates to an antibacterial nursing device with multi-band synergistic phototherapy. Background Technology

[0002] As people become more health-conscious, the demand for care of intimate areas such as the vagina and breasts is increasing. However, current intimate care products on the market still have many technical shortcomings, making it difficult to meet the needs for precise, safe, and multifunctional care.

[0003] In the field of vaginal care, existing products are mostly single antibacterial agents (such as suppositories and gels). These products can only achieve basic antibacterial effects and cannot take into account the function of soothing sensitive mucous membranes. Moreover, due to the many folds in the vaginal mucosa, ordinary agents are difficult to cover evenly, resulting in problems such as incomplete antibacterial effects and dirt residue. Some phototherapy care devices have the defect of a single light source wavelength, which can only achieve single antibacterial or repair functions and cannot meet the complex needs of maintaining the vaginal microecological balance. Summary of the Invention

[0004] To solve the above-mentioned technical problems, the present invention adopts the following technical solution: A multi-band synergistic phototherapy antibacterial care device includes: a device body and an LED light source disposed in the device body; LED light sources include, but are not limited to, blue light, red light, green light, near-blue light, and yellow light, and each light source group can be used continuously with a single wavelength or in combination with multiple wavelengths.

[0005] As a further aspect of the present invention, the wavelength ranges of each light source group in the LED light source are as follows: blue light 415nm-445nm, red light 655nm-665nm, green light 515nm-525nm, near-blue light 405nm-410nm, and yellow light 580nm-590nm.

[0006] As a further aspect of the present invention: the device body is made of a light-transmitting material, allowing the light from the LED light source to pass through efficiently.

[0007] As a further aspect of the present invention, the device body is also provided with a liquid storage tank and a micro liquid pump. The liquid storage tank is filled with an antibacterial composition, which is delivered from the device body through the micro liquid pump.

[0008] As a further aspect of the present invention, a high-frequency micro vibration motor is also provided in the device body.

[0009] As a further embodiment of the present invention: the antibacterial composition comprises, by weight: 1.0-2.0 parts of ε-polylysine, 0.3-0.7 parts of vitamin B, 0.2-0.4 parts of sodium lignosulfonate, 18.0-22.0 parts of zein and hydroxypropyltrimethylammonium chloride chitosan complex, 0.05-0.15 parts of calcium peroxide, 1.0-2.0 parts of sodium lauryl ether sulfate, 1.0-2.0 parts of cocamidopropyl betaine, 1.0-2.0 parts of glycerol, 0.8-1.2 parts of trehalose, 0.05-0.15 parts of sodium benzoate, with the remainder being citric acid, used to adjust the pH of the composition to 4.0-4.4.

[0010] As a further aspect of the present invention: the antibacterial composition is in the form of a lyophilized gel, which is pumped out by a micro-liquid pump during use and reconstituted in body fluids or water to form a gel state.

[0011] As a further aspect of the present invention, the particle size of calcium oxide is 5 micrometers.

[0012] As a further aspect of the present invention: Vitamin B is Vitamin B1.

[0013] The beneficial effects of this invention are as follows: By setting multiple specific wavelengths of light and combining them with flexible light combination modes, it precisely meets the different care needs of intimate areas such as the vagina and breasts. Each light can support independent use of a single wavelength or alternating use of multiple wavelengths. Through diverse light selection and combination design, it can be specifically adapted to the needs of different scenarios such as daily vaginal care, antibacterial protection, sensitivity soothing, breast blood circulation promotion, damage repair, and skin brightening and care. It comprehensively covers the multi-dimensional needs of intimate area care, effectively solving the problem that the single wavelength light source in the prior art has a limited care effect and cannot adapt to complex care needs, thus improving the accuracy and comprehensiveness of care. Attached Figure Description

[0014] Figure 1 This is a schematic diagram of the structure of the present invention. Detailed Implementation

[0015] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. It should be understood that this application is not limited to the exemplary embodiments disclosed herein. All other embodiments obtained by those skilled in the art based on the embodiments of this application without creative effort are within the scope of protection of this application.

[0016] In the description of this invention, it should be understood that the terms "length", "width", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this invention.

[0017] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of this invention, "a plurality of" means two or more, unless otherwise explicitly specified.

[0018] In the embodiments of this invention, unless otherwise explicitly specified and limited, the terms "installation," "connection," "linking," "fixing," etc., should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral part; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium; they can refer to the internal communication of two components or the interaction between two components. Those skilled in the art can understand the specific meaning of the above terms in this invention according to the specific circumstances.

[0019] This invention provides reference to [the relevant document]. Figure 1 In this embodiment of the invention, please refer to [reference needed]. Figure 1 In this embodiment of the invention, a multi-band synergistic phototherapy antibacterial care device includes: a device body 2 and a phototherapy module and an antibacterial module disposed in the device body 2; The phototherapy module includes an LED light source 1, which can be set at any position on the device body 2 according to different usage requirements.

[0020] LED light source 1 includes: blue light, red light, green light, near-blue light and yellow light groups; other light source groups with antibacterial effects can also be used. Each light source group can be selected to use a single wavelength continuously or to use a multi-wavelength combination and alternating mode according to the usage needs, adapting to the precise needs of different parts of the care scenario. At the same time, the effect of ambient lighting decoration can be achieved through the cooperation of multiple light source groups. The specific effects and wavelength ranges corresponding to each light source group are as follows: Blue light at 415nm-445nm has a strong antibacterial and bactericidal effect, especially effective against common harmful bacteria in the vagina such as Candida albicans and anaerobic bacteria. It is also gentle and non-irritating, making it suitable for antibacterial treatment of mucous membranes. Near blue light 405nm-410nm, it has both auxiliary bactericidal and disinfection effects and a gentle effect of promoting keratin metabolism; Red light at 655nm-665nm can penetrate the skin surface and reach the area around the breast tissue, promoting local blood circulation in the breast, helping to repair soft tissues such as minor nipple damage during lactation, and can also relieve post-inflammatory pigmentation. Green light (515nm-525nm) can soothe sensitive skin in areas such as the breasts and vulva, reducing redness and burning sensations. Yellow light at 580nm-590nm can enhance the vitality of breast skin cells, improve dull skin, and soothe mild inflammation in the vaginal area.

[0021] Furthermore, during use, this solution employs multi-band LED light sources working synergistically, using alternating combinations of multiple different wavelengths to meet diverse phototherapy needs; taking routine vaginal care and breast care as examples: Vaginal care mode: Blue light, near-blue light and green light can be used alternately. Blue light can effectively inhibit harmful bacteria such as Candida albicans and anaerobic bacteria in the vagina; near-blue light can help clean dirt and dead skin cells in the folds of the mucous membrane, which is suitable for the prevention of vaginitis and daily antibacterial cleaning; at the same time, while ensuring the antibacterial effect, green light can soothe the vulva and vaginal mucosa.

[0022] Breast care mode: Red light, yellow light and green light can be used alternately. Red light penetrates deep into the breast tissue to promote blood circulation and accelerate the repair of minor nipple damage. Yellow light improves the dullness of breast skin and enhances its luster, which is suitable for nipple repair during lactation. Green light soothes the sensitivity and discomfort of breast skin caused by friction and hormonal changes.

[0023] To verify the phototherapy efficacy and safety of the targeted multi-band LED light source combination 1 in the care of the vagina and breast intimate areas, and to clarify the efficacy of different light source combinations in achieving core care goals such as antibacterial, repair, and soothing, this controlled trial was conducted.

[0024] Experimental conditions: light intensity 5-10 mW / cm², single irradiation time 10 min, continuous irradiation for 7 days; Evaluation criteria: Based on GB / T16886.10-2017 biocompatibility standard, VAS pain / burning sensation score (0-10 points, the lower the score, the higher the comfort level), bacterial count standard, etc. Experiment Summary: This experiment verified the significant phototherapy effect of targeted light source combinations in the care of the vagina and breast intimate areas.

[0025] The vaginal care uses an alternating mode of blue light, near-blue light, and green light to achieve three core effects: blue light has an inhibition rate of over 99% against Candida albicans and anaerobic bacteria, effectively ensuring the balance of the vaginal microecology; near-blue light assists in cleaning dirt from mucosal folds, with a removal rate of 80.95%; and green light effectively soothes mucosal sensitivity, with a burning sensation relief rate of over 70%.

[0026] Breast care utilizes an alternating pattern of red, yellow, and green light. Red light increases local blood flow velocity by 35.20%, contributing to a 95% healing rate for nipple damage. Yellow light significantly improves skin radiance (by 28.57%), addressing dullness. Green light alleviates skin sensitivity and stinging with nearly 70% relief, demonstrating excellent soothing effects. In summary, this combination of targeted light sources precisely matches the different care needs of the vagina and breasts, achieving comprehensive care effects of antibacterial, repair, and soothing through multi-wavelength synergy. No significant irritation was observed during the trial, validating both safety and effectiveness.

[0027] The antibacterial module includes a reservoir 4 and a micro pump 3, wherein the reservoir 4 is filled with an antibacterial composition suitable for vaginal care; the composition is delivered from the reservoir 4 by the micro pump 3; the LED light source begins to irradiate after the antibacterial composition is applied, and the irradiation time is not less than 10 minutes.

[0028] The antibacterial composition can serve as an auxiliary medium for light transmission, enhancing the local penetration efficiency of LED light in the phototherapy module. This allows antibacterial wavelengths such as blue light and near-blue light to more precisely target harmful bacteria in mucosal folds, while repair wavelengths such as red light and green light can better penetrate into the deeper layers of the mucosa, promoting the repair of the mucosal barrier.

[0029] The device body 2 is equipped with a care head 5 adapted for vaginal and breast intimate area care. The antibacterial module's liquid storage tank 4 and micro liquid pump 3 are integrated inside the care head 5 to achieve close-range and precise delivery of the antibacterial composition. Meanwhile, the nursing head 5 is equipped with a built-in high-frequency miniature vibration motor, which can achieve linear or composite vibration output. This vibration can promote local blood circulation under the vaginal mucosa and breast skin, creating a better physiological environment for the light effect of the phototherapy module. Accelerated blood circulation can improve tissue oxygen supply and metabolic efficiency, allowing the biological effects of repair wavelengths such as red and yellow light to be more fully exerted, thereby improving the repair rate of damaged mucosa and skin. On the other hand, gentle vibration can make the reconstituted gel-like antibacterial composition spread evenly and adhere closely to the tissue surface, reducing light refraction loss and increasing the local concentration of antibacterial wavelengths such as blue and violet light. This provides a dual care effect of antibacterial and repair.

[0030] Furthermore, the device body 2 is made of light-transmitting material, which allows the light from the LED light source 1 to penetrate efficiently and improve the phototherapy effect; and the device itself achieves sterilization and disinfection effects when not in use by using blue light, near-blue light or independently set violet light of 380-450 nm in the LED light source 1.

[0031] In this embodiment, the antibacterial composition comprises, by weight: 1.0-2.0 parts of ε-polylysine, 0.3-0.7 parts of vitamin B, 0.2-0.4 parts of sodium lignosulfonate, 18.0-22.0 parts of zein and hydroxypropyltrimethylammonium chloride chitosan complex, 0.05-0.15 parts of calcium peroxide, 1.0-2.0 parts of sodium lauryl ether sulfate, 1.0-2.0 parts of cocamidopropyl betaine, 1.0-2.0 parts of glycerol, 0.8-1.2 parts of trehalose, 0.05-0.15 parts of sodium benzoate, with the remainder being citric acid, used to adjust the pH of the composition to 4.0-4.4.

[0032] The preparation method of the above antibacterial composition is as follows: S1. Add SL and vitamin B to deionized water, stir at 50℃ for 1 h, cool to 25℃, adjust pH to 5.0 to obtain SL aqueous solution; add 0.1M HCl dropwise, slowly add CaO2 powder to SL aqueous solution, maintain pH to 6.0-6.2, then ultrasonically disperse in an ice bath (0-4℃) (power 200W, 10 min); add trehalose, freeze dry to obtain SL-CaO2 lyophilized powder; the freeze drying program is -40℃ pre-freeze for 4 h, -20℃ sublime for 12 h; S2. Slowly add a 2% (w / w) zein / ethanol solution to a 2% (w / w) hydroxypropyltrimethylammonium chloride chitosan aqueous solution, maintaining the pH of the reaction solution at 6, and stir thoroughly; remove ethanol by rotary evaporation, centrifuge, and freeze-dry the supernatant to obtain a zein / hydroxypropyltrimethylammonium chloride chitosan complex; add SL-CaO2 freeze-dried powder to the zein / hydroxypropyltrimethylammonium chloride chitosan complex and other components (ε-polylysine, sodium lauryl ether sulfate, cocamidopropyl betaine, glycerol, sodium benzoate), and then adjust the pH to 4.2 using citric acid to obtain the drug solution; S3. The drug solution is injected through needle 1 (inner diameter 0.5mm), and the antibacterial composition co-extruded and packaged with CO2 is simultaneously introduced through needle 2 (annular gap 0.1mm).

[0033] The technical solutions described in the embodiments of this application have at least the following technical effects or advantages: Sodium lignosulfonate (SL) is a natural polymeric surfactant whose main function is steric stabilization, preventing CaO2 nanoparticles from agglomerating and settling in aqueous solutions, thus ensuring a uniform and stable dispersion system. SL, together with trehalose, acts as a freeze-drying protectant, forming a porous network framework that physically encapsulates CaO2 particles and vitamin B, preventing ice crystals from damaging the structure and improving the product's resolubility and stability. Sodium lignosulfonate also has film-forming properties, allowing the drug solution to adhere to the application site for a longer period after application. By removing water from the system through freeze-drying, vitamin B is transferred from an aqueous environment prone to hydrolysis to a stable solid "dormant" state, achieving physical isolation. CaO2 exhibits slow-release properties, gradually generating hydrogen peroxide in water, and the generated calcium ions promote skin barrier repair. The final pH adjustment to 4.2 accelerates the reaction rate of calcium peroxide, ensuring continuous hydrogen peroxide release during use. This pH environment not only stabilizes vitamin B but also inhibits fungal growth. ε-polylysine, being positively charged, can disrupt the negatively charged cell membranes of microorganisms. The H2O2 generated by CaO2 oxidizes and destroys the cell wall, making it easier for ε-polylysine to enter the cell. The different target sites of the two components create a synergistic effect, reducing their respective effective concentrations, increasing bactericidal efficiency, and potentially slowing the development of drug resistance. The zein / chitosan complex forms micelles, acting as a carrier to encapsulate the SL-CaO2 lyophilized powder (containing vitamin B and CaO2), protecting the stability of vitamin B and CaO2. The chitosan derivative has mucosal adhesion properties, prolonging the drug's residence time at the infection site. The complex can more effectively deliver bactericidal components deep into fungal hyphae or biofilms. An experiment was designed to verify its mechanism of action. Specifically, Candida albicans was selected, inoculated into solid culture medium and cultured overnight, then inoculated into broth and cultured at 37°C until the logarithmic growth phase. The turbidity was adjusted to 0.5 McFarland standard with physiological saline. The drug solution was then serially diluted on 96-well plates, and 10 μl of bacterial suspension was added. The plates were incubated at 37°C for 24 h. The minimum drug concentration for sterility and the minimum drug concentration for complete inhibition of bacterial growth were determined (referencing CLSIM100). The experimental groups are shown in Table 1. Table 1 Experimental Grouping in Example 1 The results are shown in Table 2; Table 2. Results of the antibacterial experiment in Example 1 Group number Experimental Groups SL dosage (per serving) CaO2 dosage (parts) MIC value (μg / mL) MFC value (μg / mL) 1 Complete solution group 0.3 0.1 62 126 2 CaO2-free group 0.3 0.0 426 ＞1000 3 No SL group 0.0 0.1 253 496 4 Blank control group - - - - 5 SL half group 0.15 0.1 126 243 6 SL Double Group 0.6 0.1 68 123 7 CaO2 halved group 0.3 0.05 118 267 8 CaO2 double group 0.3 0.2 38 62 9 Both SL and CaO2 were halved. 0.15 0.05 252 511 10 Both SL and CaO2 are doubled 0.6 0.2 30 58 Then, an accelerated test was conducted on the antibacterial composition. The accelerated test was carried out for 6 months at 36°C and 60% humidity. The content of vitamin B was then detected by HPLC. The results are shown in Table 3. Table 3. Accelerated Test Results of Example 1 Experimental Groups VB residue after accelerated testing (HPLC) Pure Vitamin B group 49.7% Complete solution group 98.3% SL half group 92.9% <![CDATA[CaO2 double group]]> 97.2% Example 2: The above example enhances the antibacterial effect and maintains the shelf life of vitamin B through the antibacterial combination; in addition, hydrogen peroxide can generate oxygen bubbles, which open up the mucus pores and increase the drug effect. It can also be used in conjunction with LEDs with wavelengths of 415-660nm for sterilization without affecting vitamin B. However, due to the presence of surfactants, the bubble retention time and number are insufficient, making it difficult to achieve the expected effect. Therefore, further improvements are made based on Example 1.

[0034] CaO2 powder was mixed with SL solution and circulated under negative pressure (-0.1MPa, 3 times) to obtain a suspension; 1 μm SiO2 microbubbles (10 wt% solid content) were dropped into the suspension and sonicated (200 W, 5 min). SiO2 microbubbles were prepared by emulsification followed by calcination to remove the template. (Ethanol, water, and ammonia were mixed and stirred at 40°C for 10 minutes; TEOS was slowly added dropwise (at a rate of 1 mL / min), and stirring was continued for 6 hours; PEG6000 was added, and the mixture was aged at 55°C and 65% RH for 24 hours, followed by the addition of 1% F-68 to obtain an aqueous phase; the aqueous phase was then subjected to microfluidic control at 0.1 bar, 300 μL / min oil phase-silicone oil, 2% Span80, and 60 μL / min aqueous phase; the temperature was then increased to 300°C at 5°C / min, held for 1 hour, then increased to 480°C, held for 2 hours, and allowed to cool naturally. After modification using DMSA, the final product was obtained.) The mixture of trehalose and glycerol was added for coating, pre-frozen at -40°C for 4 hours, and then sublimated under vacuum at -20°C for 12 hours to obtain SL-CaO2 lyophilized powder.

[0035] The technical solutions described in the embodiments of this application have at least the following technical effects or advantages: Traditional oxygen bubbles are metastable structures encapsulated by surfactant molecular films, making them highly prone to rupture. SiO2 microbubbles, on the other hand, are rigid, hollow, porous solid particles. When CaO2 reacts to produce oxygen, the oxygen enters and is stored within the cavities and porous network of the SiO2 microbubbles. The rigid shell of the SiO2 microbubbles resists external pressure, preventing the bubbles from being compressed and ruptured. Their hydrophobic surfaces (after modification) effectively trap gas molecules, preventing the gas from diffusing too quickly into the aqueous phase. Acting as miniature "gas reservoirs," this significantly extends the bubble's retention time, enabling sustained and controllable gas release. The bubbles are no longer fleeting but persist, providing sufficient time to "open up the pores of the mucus network," enhancing drug penetration and efficacy.

[0036] When CaO2 produces H2O2, it is directly activated by blue light of a specific wavelength, generating more hydroxyl radicals (·OH) with strong killing power. SiO2 microbubbles prolong the residence time of oxygen and H2O2, providing a continuous and sufficient substrate for photodynamic reactions, thereby significantly enhancing the photo-sterilization effect. Under 415nm light, hydroxyl radicals can be generated, while at a wavelength of 660nm, oxygen bubbles can be triggered to expand, triggering more light to enter, increasing the sterilization effect, and promoting cellular uptake.

[0037] A mixture of glycerol and trehalose is more effective as a freeze-drying protectant than trehalose alone, forming a more perfect amorphous glassy state and better protecting the activity of vitamin B and CaO2.

[0038] The combined illumination with LEDs in this embodiment has a stronger antibacterial effect; as shown in Table 4; Table 4 Antibacterial effect of Example 2 The device body of this application also includes a circuit section, which provides a stable power supply to the phototherapy module, antibacterial module, and vibration motor, and controls the working status of each module. It should be noted that the aforementioned circuit section is not an innovative aspect of this application; its power supply principle and control logic are common knowledge to those skilled in the art, and can be constructed using conventional circuit design concepts. Therefore, this application does not describe it in detail, but focuses only on the core innovative collaborative design of the phototherapy module and antibacterial module and the implementation of related functions.

[0039] It should also be noted that, in this document, relational terms such as "first" and "second" are used only to distinguish one entity or operation from another, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Furthermore, the terms "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such a process, method, article, or apparatus. Without further limitations, an element defined by the phrase "comprising one..." does not exclude the presence of other identical elements in the process, method, article, or apparatus that includes said element.

[0040] The above description of the disclosed embodiments enables those skilled in the art to make or use this application. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of this application. Therefore, this application is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A multi-band synergistic phototherapy antibacterial care device, characterized in that, include: The device body and the LED light source installed in the device body; LED light sources include, but are not limited to, blue light, red light, green light, near-blue light, and yellow light, and each light source group can be used continuously with a single wavelength or in combination with multiple wavelengths.

2. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 1, characterized in that, The wavelength ranges of each light source group in the LED light source are as follows: blue light 415nm-445nm, red light 655nm-665nm, green light 515nm-525nm, near-blue light 405nm-410nm, and yellow light 580nm-590nm.

3. A multi-band synergistic phototherapy antibacterial care device according to any one of claims 1 or 2, characterized in that, The device body is made of light-transmitting material, allowing the light from the LED light source to pass through efficiently.

4. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 1, characterized in that, The device body also includes a liquid storage tank and a micro liquid pump. The liquid storage tank is filled with an antibacterial composition, which is delivered from the device body through the micro liquid pump.

5. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 1, characterized in that, The device also contains a high-frequency micro vibration motor.

6. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 1, characterized in that, The antibacterial composition comprises, by weight: 1.0-2.0 parts of ε-polylysine, 0.3-0.7 parts of vitamin B, 0.2-0.4 parts of sodium lignosulfonate, 18.0-22.0 parts of zein and hydroxypropyltrimethylammonium chloride chitosan complex, 0.05-0.15 parts of calcium peroxide, 1.0-2.0 parts of sodium lauryl ether sulfate, 1.0-2.0 parts of cocamidopropyl betaine, 1.0-2.0 parts of glycerol, 0.8-1.2 parts of trehalose, 0.05-0.15 parts of sodium benzoate, with the remainder being citric acid, used to adjust the pH of the composition to 4.0-4.

4.

7. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 6, characterized in that, The antibacterial composition is in the form of a lyophilized gel. When used, it is pumped out by a micro-liquid pump and reconstituted in body fluids or water to form a gel.

8. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 6, characterized in that, The particle size of calcium oxide is 5 micrometers.

9. The antibacterial nursing device for multi-band synergistic phototherapy according to claim 6, characterized in that, Vitamin B is vitamin B1.

Images